Contributor Page
Reed Smith
Email  |  Website  |  Articles
Contact Details
Tel: +1 412 2883131
Fax: +1 412 2883063
Reed Smith Centre
225 Fifth Avenue
United States
By Stephen J. McConnell
Perhaps you have heard that elections have consequences. That is true not only for high-profile issues that hog the headlines on CNN and Fox News, but it is also true for drug and device litigation regulation.
By Matthew Jacobson
On December 5, 2017, the U.S. Food and Drug Administration (FDA) released the final version of its guidance entitled "Technical Considerations for Additive Manufactured Medical Devices; Guidance ...
By James Beck
Our only other encounter with Kentucky FDCA-based negligence per se claims involved a misbegotten case that held such a claim wasn't preempted, but didn't address the claim's viability under state law.
By Jonathan Maddison, Sebastian C. Watt
Taxpayers should closely monitor this litigation and new state efforts to enforce their sales and use tax laws in the future.
By Rachel B. Weil
Last week, we took a short Western Caribbean cruise to celebrate a jarringly-advanced birthday.
By Miriam Edelstein
On January 9, 2018, Reed Smith attorney Miriam Edelstein co-presented a panel discussion on the impact of the #MeToo movement in the workplace at the January meeting ...
By Debra McCurdy
CMS is requesting information from the public on potential changes to longstanding Clinical Laboratory Improvement Amendments of 1988 (CLIA) personnel, histocompatibility, and related policies...
By James Beck
In Bristol-Myers Squibb Co. v. Superior Court, 137 S. Ct. 1773 (2017) ("BMS") [ed. note – our post here], the United States Supreme Court concluded that specific jurisdiction must be premised on a defendant's...
By Douglas Wood
The Association of National Advertisers recently asked me for predictions on legal challenges brands will be facing in 2018.
By David P. Dorner, Jeremy Gove
The Department denied Waste Management's refund claims, and the matter was appealed to the Tribunal.
By Debra McCurdy
The DOJ notes that 669 qui tam suits were filed this past year.
By Stephen J. McConnell
Today we are talking about a case that is not exactly in the heartland of what we generally examine. It is not a product liability or mass tort case. But it is reasonably close.
By Kimberly Chow, Jason Gordon
The defendants have been ordered to pay $501,895 and may not participate in the prize promotion business or misrepresent any good or service.
By Debra McCurdy
The HHS Office of Inspector General (OIG) has published its annual solicitation of recommendations for new or revised anti-kickback statute safe harbors and new Special Fraud Alerts.
By Herbert Kozlov, Kari S. Larsen, Michael Selig
This action follows the SEC's suspension of trading in the securities of The Crypto Company announced in December 2017 and three other blockchain-related companies in the summer of 2017.
Contributor's Topics